Compare ETHZ & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ETHZ | SMTI |
|---|---|---|
| Founded | N/A | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 221.9M | 186.9M |
| IPO Year | N/A | N/A |
| Metric | ETHZ | SMTI |
|---|---|---|
| Price | $5.25 | $24.08 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $41.00 |
| AVG Volume (30 Days) | ★ 1.0M | 43.8K |
| Earning Date | 01-26-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $4,110,169.00 | ★ $101,877,532.00 |
| Revenue This Year | N/A | $21.60 |
| Revenue Next Year | N/A | $16.70 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 30.52 |
| 52 Week Low | $5.02 | $18.90 |
| 52 Week High | $174.60 | $38.68 |
| Indicator | ETHZ | SMTI |
|---|---|---|
| Relative Strength Index (RSI) | 29.16 | 50.89 |
| Support Level | $6.33 | $24.00 |
| Resistance Level | $7.05 | $25.41 |
| Average True Range (ATR) | 0.78 | 1.18 |
| MACD | -0.29 | 0.26 |
| Stochastic Oscillator | 2.87 | 44.86 |
ETHZilla Corporation is a technology company in the decentralized finance industry. It seeks to connect financial institutions, businesses and organizations worldwide by enabling secure, accessible blockchain transactions through Ethereum Network protocol implementations. It generates recurring revenues through various DeFi protocols that improve Ethereum network integrity and security. The group enables the seamless tokenization of traditional assets by bringing them on-chain. Leveraging its proprietary protocol solutions, ETHZilla supports DeFi transactions, asset digitization across various Layer 2 Ethereum networks. The platform is focused on delivering tokenization services, DeFi protocol integrations, blockchain analytics, gateways for converting traditional assets to digital forms.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.